Role of angiogenesis in tumor growth and metastasis, Seminars in Oncology, vol.29, issue.6Q, pp.15-18, 2002. ,
DOI : 10.1053/sonc.2002.37263
High grade glioma: Imaging combined with pathological grade defines management and predicts prognosis, Radiotherapy and Oncology, vol.85, issue.3, pp.371-378, 2007. ,
DOI : 10.1016/j.radonc.2007.10.008
Primetime for antiangiogenic therapy, Current Opinion in Neurology, vol.22, issue.6, 2009. ,
DOI : 10.1097/WCO.0b013e328332ba28
Emerging antiangiogenic treatments for gliomas ??? efficacy and safety issues, Current Opinion in Neurology, vol.21, issue.6, pp.736-744, 2008. ,
DOI : 10.1097/WCO.0b013e3283131370
Evaluation of the response to treatment of solid tumours ??? a consensus statement of the International Cancer Imaging Society, British Journal of Cancer, vol.138 ,
DOI : 10.1016/S0009-9260(99)91250-3
Angiogenesis in Gliomas: Imaging and Experimental Therapeutics, Brain Pathology, vol.278, issue.suppl, pp.342-363, 2005. ,
DOI : 10.1111/j.1750-3639.2005.tb00119.x
Biomarkers of response and resistance to antiangiogenic therapy, Nature Reviews Clinical Oncology, vol.14, issue.6, pp.327-338, 2009. ,
DOI : 10.1038/nrclinonc.2009.63
Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma, Proceedings of the National Academy of Sciences, vol.102, issue.46, pp.16759-16764, 2005. ,
DOI : 10.1073/pnas.0508347102
Evaluation of cancer therapy using diffusion magnetic resonance imaging, Mol Cancer Ther, vol.2, issue.6, pp.581-587, 2003. ,
Neuroimaging in neuro-oncology, Neurotherapeutics, vol.243, issue.Suppl 1, pp.465-477, 2009. ,
DOI : 10.1016/j.nurt.2009.05.002
MRI of tumor angiogenesis, Journal of Magnetic Resonance Imaging, vol.14, issue.2, pp.235-249, 2007. ,
DOI : 10.1002/jmri.20991
High-resolution longitudinal assessment of flow and permeability in mouse glioma vasculature: Sequential small molecule and SPIO dynamic contrast agent MRI, Magnetic Resonance in Medicine, vol.54, issue.3, pp.615-625, 2009. ,
DOI : 10.1002/mrm.21931
Characterization of tumor angiogenesis in rat brain using iron-based vessel size index MRI in combination with gadolinium-based dynamic contrastenhanced MRI, J Cereb Blood Flow Metab, 2009. ,
URL : https://hal.archives-ouvertes.fr/inserm-00410316
Pilot study of DCE-MRI to predict progression-free survival with sorafenib therapy in renal cell carcinoma, Cancer Biology & Therapy, vol.7, issue.4, pp.496-501, 2008. ,
DOI : 10.4161/cbt.7.4.5624
Assessment of vascular remodeling under antiangiogenic therapy using DCE-MRI and vessel size imaging, Journal of Magnetic Resonance Imaging, vol.22, issue.Spec No 1, pp.1125-1133, 2009. ,
DOI : 10.1002/jmri.21710
Dynamic MRI Using Iron Oxide Nanoparticles to Assess Early Vascular Effects of Antiangiogenic versus Corticosteroid Treatment in a Glioma Model, Journal of Cerebral Blood Flow & Metabolism, vol.25, issue.4, pp.853-860, 2009. ,
DOI : 10.1038/jcbfm.2008.162
AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients, Cancer Cell, vol.11, issue.1, pp.83-95, 2007. ,
Discovery and development of sorafenib: a multikinase inhibitor for treating cancer, Nature Reviews Drug Discovery, vol.47, issue.10, pp.835-844, 2006. ,
DOI : 10.1038/nrd2130
Sorafenib inhibits signal transducer and activator of transcription 3 signaling associated with growth arrest and apoptosis of medulloblastomas, Molecular Cancer Therapeutics, vol.7, issue.11, pp.3519-3526, 2008. ,
DOI : 10.1158/1535-7163.MCT-08-0138
Sorafenib exerts anti-glioma activity in vitro and in vivo, Neuroscience Letters, vol.478, issue.3, 2010. ,
DOI : 10.1016/j.neulet.2010.05.009
MR imaging assessment of the kinetics of P846, a new gadolinium-based MR contrast medium, in ischemically injured myocardium, Contrast Media & Molecular Imaging, vol.107, issue.3, pp.112-119, 2008. ,
DOI : 10.1002/cmmi.237
Time of death of CNS tumor-bearing rats can be reliably predicted by body weight-loss patterns, Lab Anim Sci, vol.41, issue.3, pp.269-273, 1991. ,
study, NMR in Biomedicine, vol.90, issue.3, pp.1043-1056, 2008. ,
DOI : 10.1002/nbm.1278
URL : https://hal.archives-ouvertes.fr/inserm-00861168
Diffusion-Weighted MRI in the Body: Applications and Challenges in Oncology, American Journal of Roentgenology, vol.188, issue.6, pp.1622-1635, 2007. ,
DOI : 10.2214/AJR.06.1403
Inhibition of Vascular Endothelial Growth Factor (VEGF) Signaling in Cancer Causes Loss of Endothelial Fenestrations, Regression of Tumor Vessels, and Appearance of Basement Membrane Ghosts, The American Journal of Pathology, vol.165, issue.1, pp.35-52, 2004. ,
DOI : 10.1016/S0002-9440(10)63273-7
Tumor microvascular changes in antiangiogenic treatment: Assessment by magnetic resonance contrast media of different molecular weights, Journal of Magnetic Resonance Imaging, vol.10, issue.1, pp.138-144, 2004. ,
DOI : 10.1002/jmri.20049
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy, Science, vol.307, issue.5706, pp.58-62, 2005. ,
DOI : 10.1126/science.1104819
Quantitative Analysis of Dynamic Gd-DTPA Enhancement in Breast Tumors Using a Permeability Model, Magnetic Resonance in Medicine, vol.26, issue.4, pp.564-568, 1995. ,
DOI : 10.1002/mrm.1910330416
Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts, Magnetic Resonance in Medicine, vol.113, issue.2 ,
DOI : 10.1002/mrm.1910170208
Characterization of Tumor Angiogenesis in Rat Brain Using Iron-Based Vessel Size Index MRI in Combination with Gadolinium-Based Dynamic Contrast-Enhanced MRI, Journal of Cerebral Blood Flow & Metabolism, vol.10, issue.10, pp.1714-1726, 2009. ,
DOI : 10.1002/nbm.881
URL : https://hal.archives-ouvertes.fr/inserm-00410316
Methodology of brain perfusion imaging, Journal of Magnetic Resonance Imaging, vol.11, issue.Suppl 5, pp.496-520, 2001. ,
DOI : 10.1002/jmri.1073
Quantitative BOLD: Mapping of human cerebral deoxygenated blood volume and oxygen extraction fraction: Default state, Magnetic Resonance in Medicine, vol.48, issue.1 ,
DOI : 10.1002/mrm.21108